RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.38−0.01 (-1.60%)
Close on Nov 13, 2026Market cap $1.91MP/E –Yield –
RedHill Biopharma cash
Cash and short-term investments held at the end of each period.
RedHill Biopharma's cash was $5.16M at Jun 30, 2026. For fiscal 2025 it was $3.97M, down 14.0% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $53.79M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.97M | -14.0% |
| FY2024 | Dec 31, 2024 | $4.62M | -17.1% |
| FY2023 | Dec 31, 2023 | $5.57M | -72.1% |
| FY2022 | Dec 31, 2022 | $19.97M | -32.3% |
| FY2021 | Dec 31, 2021 | $29.47M | +0.6% |
| FY2020 | Dec 31, 2020 | $29.30M | +0.9% |
| FY2019 | Dec 31, 2019 | $29.02M | +0.1% |
| FY2018 | Dec 31, 2018 | $29.01M | +76.3% |
| FY2017 | Dec 31, 2017 | $16.46M | -69.4% |
| FY2016 | Dec 31, 2016 | $53.79M | +150.0% |
| FY2015 | Dec 31, 2015 | $21.52M | +265.2% |
| FY2014 | Dec 31, 2014 | $5.89M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.16M | -29.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.97M | -28.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.87M | -59.0% |
| Q4 FY2024 | Dec 31, 2024 | $4.62M | -76.9% |
| Q2 FY2024 | Jun 30, 2024 | $7.28M | -73.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.57M | -80.7% |
| Q2 FY2023 | Jun 30, 2023 | $7.00M | -76.3% |
| Q4 FY2022 | Dec 31, 2022 | $19.97M | -61.5% |
| Q2 FY2022 | Jun 30, 2022 | $26.99M | -64.5% |
| Q1 FY2022 | Mar 31, 2022 | $28.85M | -1.5% |
| Q4 FY2021 | Dec 31, 2021 | $29.47M | +32.3% |
| Q2 FY2021 | Jun 30, 2021 | $51.82M | -36.5% |
| Q1 FY2021 | Mar 31, 2021 | $75.97M | +161.8% |
| Q4 FY2020 | Dec 31, 2020 | $29.30M | +225.7% |
| Q2 FY2020 | Jun 30, 2020 | $22.27M | -3.2% |
| Q1 FY2020 | Mar 31, 2020 | $81.61M | +181.4% |
| Q4 FY2019 | Dec 31, 2019 | $29.02M | +421.6% |
| Q2 FY2019 | Jun 30, 2019 | $9.00M | +19.0% |
| Q1 FY2019 | Mar 31, 2019 | $23.01M | +39.9% |
| Q4 FY2018 | Dec 31, 2018 | $29.01M | +89.3% |
| Q2 FY2018 | Jun 30, 2018 | $5.56M | -81.2% |
| Q1 FY2018 | Mar 31, 2018 | $7.56M | -85.9% |
| Q4 FY2017 | Dec 31, 2017 | $16.46M | -23.5% |
| Q2 FY2017 | Jun 30, 2017 | $15.32M | +160.0% |
| Q1 FY2017 | Mar 31, 2017 | $29.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.79M | – |
| Q4 FY2015 | Dec 31, 2015 | $21.52M | – |
| Q4 FY2014 | Dec 31, 2014 | $5.89M | – |
See a number that looks wrong?